Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 6
1999 6
2000 9
2001 4
2002 1
2003 6
2004 5
2005 12
2006 10
2007 12
2008 16
2009 18
2010 24
2011 20
2012 12
2013 13
2014 22
2015 43
2016 22
2017 22
2018 24
2019 21
2020 39
2021 34
2022 35
2023 27
2024 35
2025 31
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

492 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean brachman p[au] (84 results)?
Psoriatic arthritis from a mechanistic perspective.
Schett G, Rahman P, Ritchlin C, McInnes IB, Elewaut D, Scher JU. Schett G, et al. Among authors: rahman p. Nat Rev Rheumatol. 2022 Jun;18(6):311-325. doi: 10.1038/s41584-022-00776-6. Epub 2022 May 5. Nat Rev Rheumatol. 2022. PMID: 35513599 Review.
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Mease PJ, Rahman P, Gottlieb AB, Kollmeier AP, Hsia EC, Xu XL, Sheng S, Agarwal P, Zhou B, Zhuang Y, van der Heijde D, McInnes IB; DISCOVER-2 Study Group. Mease PJ, et al. Among authors: rahman p. Lancet. 2020 Apr 4;395(10230):1126-1136. doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13. Lancet. 2020. PMID: 32178766 Free article. Clinical Trial.
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landewé R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S; FUTURE 2 Study Group. McInnes IB, et al. Among authors: rahman p. Lancet. 2015 Sep 19;386(9999):1137-46. doi: 10.1016/S0140-6736(15)61134-5. Epub 2015 Jun 28. Lancet. 2015. PMID: 26135703 Free article. Clinical Trial.
Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study.
Mease PJ, Ritchlin CT, Coates LC, Kollmeier AP, Zhou B, Jiang Y, Bensley K, Im K, Batra R, Chakravarty SD, Rahman P, van der Heijde D. Mease PJ, et al. Among authors: rahman p. Ann Rheum Dis. 2025 Dec;84(12):1983-1994. doi: 10.1016/j.ard.2025.08.006. Epub 2025 Sep 17. Ann Rheum Dis. 2025. PMID: 40962616 Free article. Clinical Trial.
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study.
Mease P, van der Heijde D, Landewé R, Mpofu S, Rahman P, Tahir H, Singhal A, Boettcher E, Navarra S, Meiser K, Readie A, Pricop L, Abrams K. Mease P, et al. Among authors: rahman p. Ann Rheum Dis. 2018 Jun;77(6):890-897. doi: 10.1136/annrheumdis-2017-212687. Epub 2018 Mar 17. Ann Rheum Dis. 2018. PMID: 29550766 Free PMC article. Clinical Trial.
The APLAR Recommendations for the Management of Psoriatic Arthritis.
Leung YY, Bird P, Haroon M, Kishimoto M, Shin K, Mathew AJ, Reyes H, Chau J, Neuen D, Chiowchanwisawakit P, Ridha AA, Xu C, Taylor W, Yahya F, So H, Fukui S, Van Hung N, Soroosh SG, Wahono CS, Pok LSL, Gonzales JR, Yeo YW, Dandeniya C, Morita A, Rahman PA, Basim S, Deshapriya K, Satti E, Phong ND, Kim MJ, Jha A, Cackamvalli PM, Rafique A, Islam MN, Tam LS. Leung YY, et al. Among authors: rahman pa. Int J Rheum Dis. 2025 Aug;28(8):e70372. doi: 10.1111/1756-185x.70372. Int J Rheum Dis. 2025. PMID: 40725984
Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis.
McInnes IB, Rahman P, Gottlieb AB, Hsia EC, Kollmeier AP, Xu XL, Jiang Y, Sheng S, Shawi M, Chakravarty SD, van der Heijde D, Mease PJ. McInnes IB, et al. Among authors: rahman p. Arthritis Rheumatol. 2022 Mar;74(3):475-485. doi: 10.1002/art.42010. Epub 2022 Feb 7. Arthritis Rheumatol. 2022. PMID: 34719872 Free PMC article. Clinical Trial.
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, Thomas LF, Traks T, Uebe S, Assmann G, Baudry D, Behrens F, Billi AC, Brown MA, Burkhardt H, Capon F, Chung R, Curtis CJ, Duckworth M, Ellinghaus E, FitzGerald O, Gerdes S, Griffiths CEM, Gulliver S, Helliwell PS, Ho P, Hoffmann P, Holmen OL, Huang ZM, Hveem K, Jadon D, Köhm M, Kraus C, Lamacchia C, Lee SH, Ma F, Mahil SK, McHugh N, McManus R, Modalsli EH, Nissen MJ, Nöthen M, Oji V, Oksenberg JR, Patrick MT, Perez White BE, Ramming A, Rech J, Rosen C, Sarkar MK, Schett G, Schmidt B, Tejasvi T, Traupe H, Voorhees JJ, Wacker EM, Warren RB, Wasikowski R, Weidinger S, Wen X, Zhang Z; BSTOP study group; Estonian Biobank research team; Barton A, Chandran V, Esko T, Foerster J, Franke A, Gladman DD, Gudjonsson JE, Gulliver W, Hüffmeier U, Kingo K, Kõks S, Liao W, Løset M, Mägi R, Nair RP, Rahman P, Reis A, Smith CH, Di Meglio P, Barker JN, Tsoi LC, Simpson MA, Elder JT. Dand N, et al. Among authors: rahman p. Nat Commun. 2025 Feb 28;16(1):2051. doi: 10.1038/s41467-025-56719-8. Nat Commun. 2025. PMID: 40021644 Free PMC article.
Traduction franco-canadienne de l’Assessment of Systematic Reviews Revised (AMSTAR 2) : validation transculturelle et fidélité interjuges.
Flowers H, Guitard P, King J, Fitzpatrick E, Bérubé D, Barette JA, Cardinal D, Cavallo S, O'Neil J, Charette M, Côté L, Gurgel-Juarez NC, Toupin-April K, Shallwani SM, Dorion M, Rahman P, Potvin-Gilbert M, Bartolini V, Lewis KB, Martini R, Lagacé J, Galipeau R, Ranger MC, Duquette-Laplante F, Perrier MF, Savard J, Paquet N, Tourigny J, Bérubé ME, Ba Haroon H, Duong P, Bigras J, Capistran J, Loew L. Flowers H, et al. Among authors: rahman p. Physiother Can. 2022 Jan 1;74(1):15-24. doi: 10.3138/ptc-2019-0104. Epub 2021 Mar 2. Physiother Can. 2022. PMID: 35185243 Free PMC article. French.
Preface to genomics of rheumatic disease.
Barton A, Rahman P. Barton A, et al. Among authors: rahman p. Best Pract Res Clin Rheumatol. 2024 Dec;38(4):102005. doi: 10.1016/j.berh.2024.102005. Epub 2024 Sep 21. Best Pract Res Clin Rheumatol. 2024. PMID: 39306537 No abstract available.
492 results